Nuclear Imaging Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (PET Imaging Systems, Gamma Camera Imaging Systems (SPECT Imaging Systems, Planar Scintigraphy Imaging Systems)), By Application (Oncology, Cardiology, Neurology, Others), By End User (Hospitals & Clinics, Diagnostic Imaging Centers, Others), By Region and Competition, 2020-2030F

Market Overview

The Global Nuclear Imaging Equipment Market, valued at USD 3.89 Billion in 2024, is projected to experience a CAGR of 8.10% to reach USD 6.21 Billion by 2030. Nuclear imaging equipment comprises specialized medical devices utilizing radiopharmaceuticals to visualize physiological processes within the human body, facilitating the diagnosis and management of conditions such as cancer, cardiovascular ailments, and neurological disorders. The market's growth is propelled by the increasing global prevalence of chronic diseases, a sustained demand for early and accurate diagnostic tools, and ongoing technological advancements, including the development of hybrid imaging modalities. According to the European Association of Nuclear Medicine, its EANM'24 Hamburg congress in 2024 registered 8,641 total participants, underscoring the substantial professional engagement and clinical interest in the field.

A significant challenge impeding market expansion is the considerable capital investment required for nuclear imaging equipment, which includes procurement, installation, and continuous operational maintenance. This economic barrier can restrict wider adoption, particularly in healthcare systems within developing regions, thereby influencing global market penetration.

Key Market Drivers

The increasing prevalence of chronic diseases serves as a primary driver for the Global Nuclear Imaging Equipment Market. Conditions like cancer, cardiovascular ailments, and neurological disorders require advanced diagnostic tools for early detection, accurate staging, and effective treatment monitoring. Nuclear imaging provides essential physiological and metabolic information vital for managing these complex health challenges. According to the World Health Organization's International Agency for Research on Cancer (IARC), in February 2024, an estimated 20 million new cancer cases were recorded worldwide in 2022, highlighting the substantial patient demographic necessitating precise diagnostic evaluations. This escalating disease burden fuels a sustained demand for sophisticated nuclear imaging equipment across global healthcare infrastructures.

Advancements in hybrid imaging technologies also represent a significant market driver, notably enhancing the diagnostic accuracy and clinical utility of nuclear imaging systems. The integration of modalities such as Positron Emission Tomography with Computed Tomography PET/CT and Single Photon Emission Computed Tomography with Computed Tomography SPECT/CT delivers comprehensive co-registered functional and anatomical data, enabling more confident diagnoses. For instance, according to Siemens Healthineers, in June 2023, their new Biograph Vision. X PET/CT scanner offered a 20% performance improvement, facilitating faster patient throughput and reduced radiotracer expenses through advanced detector technology. These innovations improve clinical efficiency and foster broader adoption. The robust overall market activity, driven by such technological strides, is evident as, according to the World Nuclear Association Analysis, in 2024, approximately 50 million nuclear medicine procedures are performed annually worldwide, underscoring the extensive application of these systems.

Download Free Sample Report

Key Market Challenges

The considerable capital investment required for nuclear imaging equipment directly hampers the growth of the Global Nuclear Imaging Equipment Market. This significant economic barrier encompasses the costs associated with equipment procurement, complex installation processes, and continuous operational maintenance. Such high financial outlay restricts the wider adoption of these advanced diagnostic tools, particularly within healthcare systems of developing regions where budgetary constraints are more pronounced.

The financial demands often lead to delayed or forgone investments in essential nuclear imaging infrastructure. This limitation in establishing new facilities or upgrading existing ones directly impedes market expansion in areas with unmet diagnostic needs. According to the International Atomic Energy Agency's Technical Cooperation Report, in 2024, the agency delivered support to 151 countries and territories, addressing various health priorities. This widespread need for external assistance underscores the substantial financial challenges many nations face in independently acquiring and sustaining sophisticated medical technologies like nuclear imaging equipment, thereby constraining global market penetration.

Key Market Trends

The emergence of theranostics represents a significant trend within the global nuclear imaging equipment market, shifting the paradigm from purely diagnostic imaging to an integrated approach combining both diagnosis and targeted therapy. This methodology utilizes specific radiopharmaceuticals to identify disease at a molecular level and subsequently deliver a therapeutic dose to the identified target, minimizing impact on healthy tissue. This integration enables highly personalized patient management, particularly in oncology and other complex diseases. According to the European Association of Nuclear Medicine, its EANM24 annual congress in October 2024 prominently featured "The Age of Theranostics" as a plenary session, underscoring the growing clinical interest and advancements in this combined diagnostic and therapeutic field. This focus drives demand for nuclear imaging equipment capable of facilitating both precise diagnostic localization and subsequent treatment monitoring.

The increasing integration of artificial intelligence for image analysis is another pivotal trend transforming the nuclear imaging equipment market by enhancing diagnostic capabilities and operational efficiency. AI algorithms improve image quality, reduce noise, and automate the interpretation of complex scan data, leading to more accurate and timely diagnoses. This technological advancement supports clinicians by streamlining workflows and potentially uncovering subtle indicators of disease. For instance, in May 2025, GE HealthCare obtained FDA clearance for its Aurora nuclear medicine system, which incorporates deep learning AI programs like Clarify DL to boost image coherence and reduce noise across various procedures. Such integrations are vital for optimizing the performance of nuclear imaging systems and managing the growing volume of medical image data.

Segmental Insights

The PET Imaging Systems segment is experiencing rapid growth within the Global Nuclear Imaging Equipment Market due to several interconnected factors. This acceleration is largely attributable to continuous technological advancements that have significantly improved image resolution, sensitivity, and scanning speed, notably through the widespread adoption of hybrid PET/CT and emerging PET/MRI systems. These integrated modalities merge functional and anatomical data, providing clinicians with superior diagnostic precision for complex conditions. Furthermore, the increasing global prevalence of chronic diseases, particularly in oncology, cardiology, and neurology, drives demand for advanced imaging capabilities essential for early detection, accurate disease staging, and effective monitoring of treatment responses. The ongoing development and regulatory approval of novel radiopharmaceuticals by bodies such as the US Food and Drug Administration further expand PET imaging's clinical utility across a broader spectrum of medical conditions.

Regional Insights

North America leads the global nuclear imaging equipment market due to its advanced healthcare infrastructure and widespread adoption of sophisticated imaging technologies. The region's dominance is further driven by the high prevalence of chronic diseases, particularly cancer, which increases demand for early and accurate diagnostic tools. Favorable reimbursement policies significantly support the utilization of nuclear medicine procedures, while substantial public and private investments in research and development foster innovation. Additionally, a supportive regulatory environment, exemplified by the U. S. Food and Drug Administration, facilitates the introduction of new technologies and ensures market growth.

Recent Developments

• In June 2025, GE HealthCare showcased its innovative molecular imaging solutions for cardiac diagnostics, including the Flyrcado (flurpiridaz F 18) injection, at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. This first-of-its-kind F 18-unit dose PET myocardial perfusion imaging (MPI) agent was recently launched in select U.S. markets. Flyrcado is designed to offer higher diagnostic efficacy compared to conventional SPECT MPI, thereby playing a critical role in advancing cardiac care through detailed insights into biological processes.

• In April 2025, United Imaging Healthcare released its 2024 annual report, detailing significant product innovation and global expansion efforts in the medical imaging sector. Throughout 2024, the company launched over 140 new products globally, with a notable investment of CNY 2.26 billion in research and development. This included the successful installation of light-guide digital PET/CT systems at prominent nuclear medical centers in France and Germany, indicating a strong focus on advanced nuclear imaging equipment. These developments underscored the company's commitment to delivering intelligent and accessible technologies to the global market.

• In October 2024, GE HealthCare introduced Aurora, a new dual-head SPECT/CT system, at the European Association of Nuclear Medicine (EANM) Congress. This advanced nuclear imaging equipment integrates AI-powered technologies, designed to enhance diagnostic capabilities for clinicians. The system aims to broaden the range of available procedures for cardiac patients and support the detection and precise localization of abnormalities related to cancer and neurological disorders. Aurora features a wide CT bore and high-speed scanning capabilities, intending to improve patient comfort and workflow efficiency in the global nuclear imaging equipment market.

• In July 2024, Siemens Healthineers advanced its medical technology offerings with the debut of its next-generation Biograph Trinion PET/CT scanner. This new high-performance PET/CT system was unveiled with a focus on streamlining workflows for PET, CT, and post-processing. It incorporates applications crucial for oncology, theranostics, cardiovascular imaging, and neurology, including Alzheimer's disease. This launch represents a significant enhancement in the company's molecular imaging portfolio, aimed at providing improved diagnostic capabilities within the global nuclear imaging equipment market.

Key Market Players

• Siemens Healthineers AG
• GE HealthCare Technologies, Inc.
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• SurgicEye GmbH
• Mediso Ltd.
• MR Solutions Ltd.
• Segami Corporation
• Mirion Technologies (Capintec), Inc.
• Neusoft Medical Systems Co., Ltd.

Report Scope:

In this report, the Global Nuclear Imaging Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Nuclear Imaging Equipment Market, By Product Type:

o   PET Imaging Systems

o   Gamma Camera Imaging Systems

• Nuclear Imaging Equipment Market, By Application:

o   Oncology

o   Cardiology

o   Neurology

o   Others

• Nuclear Imaging Equipment Market, By End User:

o   Hospitals & Clinics

o   Diagnostic Imaging Centers

o   Others

• Nuclear Imaging Equipment Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Nuclear Imaging Equipment Market.

Available Customizations:

Global Nuclear Imaging Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Nuclear Imaging Equipment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]